A government review's six-year-old recommendations led to the decision to fund an unapproved and unapprovable product over an approved medicine. The document is the first in a series that ended with an unprecedented workaround on patient safety and confirms the truism that 'everything happens for a reason'.
-
Latest News
Companies welcome November PBAC outcomes
Several companies have welcomed recommendations from November's Pharmaceutical Benefits Advisory Committee meeting.
-
Podcast The 'Dispatched' Podcast - 'This draws a line through everything and it's not good' December 22, 2024
-
Latest News Wholesalers secure five-year agreement with the Government December 19, 2024“As climate-related disasters increase, our role is of heightened importance in reaching impacted communities during emergencies such as cyclone, flood or bushfire," said NPSA Chair Richard Vincent
-
Latest News 'Found irregularities and anomalies in the instruments of delegation from the minister' December 20, 2024One of the first things a newly-appointed health minister does is delegate their vast legislated decision-makers to officials in their department.
-
Australian Biotech FDA approves Mesoblast's cell therapy to treat steroid-refractory acute graft-versus-host disease December 19, 2024The US FDA has approved Mesoblast's Ryoncil (remestemcel-L-rknd) for treating steroid-refractory acute graft-versus-host disease (SR-aGVHD) in pediatric patients 2 months and older.
-
Latest News When the Government funds a health technology, the community makes certain assumptions December 19, 2024It is a decision that has 'broken the seal' on a long-held principle that has indisputably contributed to Australians having high public confidence in the health technologies they are administered. It is an awful decision because when the Government funds a health technology, the community makes certain assumptions that are now at risk.
-
Latest News If this decision to undermine the TGA reflects a policy decision, be transparent about it December 18, 2024Besides seriously undermining one of the world's most highly regarded regulatory agencies, stakeholders should consider the logical extension of this decision, not least for patient safety and public confidence in the health system.
-
Australian Biotech Researchers say Australia’s first mRNA vaccine candidate could address COVID ‘immune imprinting’ December 18, 2024The scientists behind Australia’s first locally developed mRNA COVID-19 vaccine candidate have published a preclinical study demonstrating the vaccine's potential to overcome the issue of ‘immune imprinting.’
-
Latest News New listings and higher prescription volumes driving PBS spend December 18, 2024The Albanese Government says it has provided $2.5 billion for new and amended listings on the PBS since the 2024-25 Budget with higher payments to the program partially driven by higher prescription volumes.
-
Podcast 'I really live with a 12-month timeframe...and I am always waiting' December 17, 2024It is personal for Dr Andrea Smith, who was diagnosed with metastatic breast cancer nine years ago. She is working on research, projects and programs to raise awareness and support for women living with what she describes as a '12-month timeframe'.
-
Latest News Auditor General finds the administration of the PBS 'partly effective' December 17, 2024The Australian National Audit Office has tabled its performance audit of the administration of the PBS, describing it as "partly effective" with changes coming in how the health department engages stakeholders and governance arrangements for the PBAC.
-
Latest News Government making it easier for itself on Safety Net but patients missing out December 18, 2024According to the Auditor General, "In 2021, Health (Department of Health and Aged Care) estimated that 640,000 patients become eligible for the Safety Net each year but do not apply, foregoing $100 million in medicine subsidies."
-
Latest News Australians with our most misunderstood arthritis receive resources in time for holidays December 17, 2024“Christmas can be particularly challenging for people with gout,” said Jonathan Smithers, the CEO of Arthritis Australia. “Misconceptions about the condition and its triggers often lead to anxiety around festive meals. This new resource hub provides practical advice to help individuals enjoy the season without compromising their health.”
-
Latest News HTA implementation group waiting for ministerial direction on priorities December 18, 2024The document confirms that Health Minister Mark Butler will direct its prioritisation of the HTA Review's 50 recommendations. "The Minister will provide to the IAG an initial list of recommendations from the HTA Review for priority consideration and may direct the IAG on its work plan from time to time," it says.
-
Latest News Call for action as pneumococcal outbreak hits 20 year high December 17, 2024The Immunisation Foundation of Australia revealed that more than 4,500 cases of severe pneumococcal, known as invasive pneumococcal disease, have been recorded in the last 24 months. This is the highest rate of diagnoses since 2002.
-
Australian Biotech Australian Medtech Manufacturing Alliance strengthens with new steering group members December 16, 2024Led by BioMelbourne Network, the new initiative brings together expertise from peak industry bodies and companies to create a voice and advocate on behalf of Victorian medtech manufacturers across the key issues impacting the sector.
-
Australian Biotech AusBiotech and BioNSW deepen collaboration with new MOU December 16, 2024AusBiotech has formalised a new partnership with BioNSW, a rapidly growing not-for-profit organisation dedicated to harnessing the full potential of the New South Wales Life Sciences sector.
-
BioPharma 'They intended to launch a product on the market when that was not their intention' December 16, 2024The Commonwealth has narrowly lost its attempt in the High Court to overturn the Federal Court's denial of compensation in a significant PBS damages case, but not without Australia's most senior legal minds delivering a damning assessment of one company's evidence.
-
Podcast The 'Week in Review' Podcast - 13 December December 13, 2024International comparisons can work both ways, the incredibly disrespectful and dismissive 'let them eat cake' attitudes of two key advisory committees and a welcome ministerial intervention that should be more broadly applied. We also answer some questions from the audience.
-
Latest News 'The demand has been higher than expected, and we’ve worked hard to make sure that it remains affordable' December 16, 2024“I’m pleased we can continue to deliver cheaper medicines for the thousands of Australians living with severe eczema," said Health Minister Mark Butler.
Australian Biotech
-
FDA approves Mesoblast's cell therapy to treat steroid-refractory acute graft-versus-host disease
December 19, 2024 -
Race Oncology appoints Opthea founder to its board
December 18, 2024 -
If you have ovarian cancer, genomic testing may open up new treatment option
December 18, 2024 -
Cartherics secures G-Rex grant to support its ‘in house’ manufacturing program
December 18, 2024 -
Researchers say Australia’s first mRNA vaccine candidate could address COVID ‘immune imprinting’
December 18, 2024
Other Health
-
BTC announced new partnership agreement with Corcym
December 9, 2024 -
NSW government backs down on health tax in new agreement with health funds
December 2, 2024 -
Ramsay Health Care and Bupa join forces to develop our next generation of nurses
November 19, 2024 -
Medibank expands four-day work week trial to 500 employees
October 9, 2024 -
Artrya submits application for Salix to the US FDA
September 30, 2024
Latest Video
New Stories
-
Companies welcome November PBAC outcomes
December 23, 2024 - - Latest News -
The 'Dispatched' Podcast - 'This draws a line through everything and it's not good'
December 22, 2024 - - Podcast -
'Found irregularities and anomalies in the instruments of delegation from the minister'
December 20, 2024 - - Latest News -
FDA approves Mesoblast's cell therapy to treat steroid-refractory acute graft-versus-host disease
December 19, 2024 - - Australian Biotech -
Wholesalers secure five-year agreement with the Government
December 19, 2024 - - Latest News -
When the Government funds a health technology, the community makes certain assumptions
December 19, 2024 - - Latest News -
If this decision to undermine the TGA reflects a policy decision, be transparent about it
December 18, 2024 - - Latest News